Zylox-Tonbridge Medical Technology Co., Ltd. (ZYLOXTB) disclosed a next-day return confirming the on-market repurchase of 51,000 H shares on 14 May 2026.

• Repurchase details – Price range: HKD 21.68–22.20 per share – Volume-weighted average price: HKD 22.03 – Aggregate consideration: HKD 1.12 million

• Capital structure after the transaction – Issued shares (excluding treasury): reduced from 327.15 million to 327.10 million, a 0.0152 % decrease – Treasury shares: increased from 9.20 million to 9.25 million – Total issued shares (including treasury): unchanged at 336.35 million

• Repurchase mandate utilisation – General mandate granted on 13 May 2026 permits repurchase of up to 32.72 million shares – Cumulative buybacks under the mandate: 102,000 shares, representing 0.0305 % of issued shares on the mandate date – Moratorium on new share issues or treasury share sales runs through 13 June 2026

The company confirmed all regulatory requirements and listing rules were observed in executing the repurchase, and all bought-back shares have been designated as treasury shares.